国际皮肤性病学杂志    2006 32 (4): 205-207   ISSN: 2096-5540  CN: 32-1880/R   皮肤外用他克莫司治疗白癜风 林晓, 傅雯雯 复旦大学附属华山医院皮肤科, 上海 200040 收稿日期 2006-01-06  修回日期 null  网络版发布日期 null 参考文献  [1] Kovacs SO.Vitiligo.J Am Acad Dermatol,1998,38(5 Pt 1):647-666. [2] Caixia T,Hongwen F,Xiran L.Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo.J Dermatol Sci,1999,21:59-62. [3] Wang X,Erf GF.Apoptosis in feathers of Smyth line chickens with autoimmune vitiligo.J Autoimmun,2004,22:21-30. [4] Wang X,Erf GF.Melanocyte-specific cell mediated immune response in vitiliginous Smyth line chickens.J Autoimmun,2003,21:149-160. [5] Austin LM,Boissy RE.Mammalian tyrosinase-related protein-1 is recognized by autoantibodies from vitiliginous Smyth chickens.An avian model for human vitiligo.Am J Pathol,1995,146:1529-1541. [6] Ruzicka T,Assmann T,Homey B.Tacrolimus:the drug for the turn of the millennium? Arch Dermatol,1999,135:574-580. [7] Marsland AM,Griffiths CE.The macrolide immunosuppressants in dermatology:mechanisms of action.Eur J Dermatol,2002,12:618-622. [8] Cheer SM,Plosker GL.Tacrolimus ointment.A review of its therapeutic potential as a topical therapy in atopic dermatitis.Am J Clin Dermatol,2001,2:389-406. [9] Nghiem P,Pearson G,Langley RG.Tacrolimus and pimecrolimus:from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis.J Am Acad Dermatol,2002,46:228-241. [10] Wollenberg A,Sharma S,von BubnoffD,et al.Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis.J Allergy Clin Immunol,2001,107:519-525. [11] Lan CC,Chen GS,Chiou MH,et al.FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes:possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo.Br J Dermatol,2005,153:498-505. [12] Smith DA,Tofte SJ,Hanifin JM.Repigmentation ofvitiligo with topical tacrolimus.Dermatology,2002,205:301-303. [13] Grimes PE,Soriano T,Dytoc MT.Topical tacrolimus for repigmentation of vitiligo.J Am Acad Dermatol,2002,47:789-791. [14] Tanghetti EA.Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo:results of a prospective patient series.Cutis,2003,71:158-162. [15] Travis LB,Weinberg JM,Silverberg NB.Successful treatment ofvitiligo with 0.1% tacrolimus ointment.Arch Dermatol,2003,139:571-4;discussion 573. [16] Passeron T,Ostovari N,Zakaria W,et al.Topical tacrolimus and the 308-nm excimer laser:a synergistic combination for the treatment of vitiligo.Arch Dermatol,2004,140:1065-1069. [17] Kanwar AJ,Dogra S,Parsad D.Topical tacrolimus for treatment of childhood vitiligo in Asians.Clin Exp Dermatol,2004,29:589-592. [18] Lepe V,Moncada B,Castanedo-Cazares JP,et al.A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.Arch Dermatol,2003,139:581-585. [19] Silverberg NB,Lin P,Travis L,et al.Tacrolimus ointment promotes repigmentation of vitiligo in children:a review of 57 cases.J Am Acad Dermatol,2004,51:760-766. [20] Reitamo S,Rissanen J,Remitz A,et al.Tacrolimus ointment does not affect collagen synthesis:results of a single-center randomized trial.J Invest Dermatol,1998,111:396-398. 通讯作者: